Virulence targeted inhibitory effect of linalool against the exclusive uropathogen Proteus mirabilis

Ravindran Durgadevi1, Arumugam Veera Ravi1, Rajaiah Alexpandi1

  • 1Department of Biotechnology, Alagappa University , Tamil Nadu , India.

Biofouling
|May 31, 2019
PubMed

Insights

Linalool, a natural compound, effectively reduces biofilm formation and virulence in Proteus mirabilis, a common cause of catheter-associated urinary tract infections (CAUTI). This suggests linalool

Area of Science:

  • Microbiology
  • Natural Product Chemistry
  • Urology

Background:

  • Proteus mirabilis is a primary cause of catheter-associated urinary tract infections (CAUTI).
  • Biofilm formation by P. mirabilis contributes to antibiotic resistance, complicating treatment.
  • Virulence factors, such as urease, promote P. mirabilis biofilm development and urinary tract issues.

Purpose of the Study:

  • To investigate the anti-biofilm and anti-virulence potential of linalool against P. mirabilis.
  • To determine the effect of linalool on urease production and biofilm-associated genes in P. mirabilis.

Main Methods:

  • In vitro assessment of linalool's anti-biofilm activity against P. mirabilis.
  • Quantification of urease activity in P. mirabilis treated with varying concentrations of linalool.
  • Quantitative PCR (q-PCR) analysis to evaluate the expression of biofilm and virulence genes.

Main Results:

  • Linalool demonstrated concentration-dependent inhibition of P. mirabilis biofilm formation.
  • Treatment with linalool led to reduced urease production, impacting urinary pH and crystal formation.
  • q-PCR results confirmed the down-regulation of key biofilm and virulence genes following linalool exposure.

Conclusions:

  • Linalool exhibits significant anti-biofilm properties against P. mirabilis.
  • Linalool effectively attenuates virulence factors, including urease production.
  • Linalool presents a promising natural agent for combating P. mirabilis-associated CAUTI.

Related Concept Videos

The Pauli Exclusion Principle03:06

The Pauli Exclusion Principle

The arrangement of electrons in the orbitals of an atom is called its electron configuration. We describe an electron configuration with a symbol that contains three pieces of information:
59.1K
Size-Exclusion Chromatography01:08

Size-Exclusion Chromatography

In size-exclusion chromatography (SEC), also known as molecular-exclusion or gel-permeation chromatography, molecules are separated based on their sizes. This technique is important for separating large molecules such as polymers and biomolecules. The two classes of micron-sized stationary phases encountered in SEC are silica particles and cross-linked polymer resin beads. Both materials are porous, but their pore sizes vary significantly.
Silica particles offer advantages such as rigidity,...
1.8K
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
12.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.3K